RSV Treatment

Respiratory Syncytial Virus Diagnostics Market Current Scenario Analysis with Forecast by 2029    BioSpace

RSV Diagnostics Market Size, Share & Trends Analysis Report by Application by Region (North America, Europe, A    openPR

Kids under age 5 may carry a much higher coronavirus viral load than older children and adults: study    MarketWatch

BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnosic Tests    Odessa American

News at a glance    Science

Five things to know for Wednesday, July 29    Buffalo Business First

Five things to know for Wednesday, July 29    Buffalo Business First

Five things to know for Wednesday, July 29    Buffalo Business First

Five things to know for Wednesday, July 29    Buffalo Business First

Prophylactic nirsevimab treatment reduces RSV risk in infants    2 Minute Medicine

Five things to know for Wednesday, July 29    Buffalo Business First

Facilitating RSV entry    Science

Enanta Pharmaceuticals to Host Conference Call on August 4 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020    Yahoo Finance

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins    Odessa American

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins    Odessa American

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins    Odessa American

NYC Skyscrapers & the Terra Cotta Revolution Interactive Webinar    Patch.com

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins    Odessa American

'Breakthrough': More progress in COVID-19 fight    RACGP

Coronavirus: How bad will winter really be?    BBC News

Synairgen drug 'prevents 79 per cent' of coronavirus cases progressing    BBC Focus Magazine

Coronavirus: How bad will winter really be?    BBC News

APhA Urges Congress to Authorize Pharmacists' COVID Testing and Immunization Services under Medicare in Next Pandemic Bill    PRNewswire

How Could a Virus be Genetically Engineered?    News-Medical.net

Particle sizes of infectious aerosols: implications for infection control    The Lancet

ClinEdge and BTC Networks Contribute to COVID-19 Vaccine Programs with Sites Selected for Three Different Large Programs    Odessa American

Governments Around the World Escalate Precautions Amid the Surge    PRNewswire

Local doctor provides tips for parents regarding this upcoming school year    KTIV

Local doctor provides tips for parents regarding this upcoming school year    KTIV

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils    Washington Post

Possible 'Breakthrough' Coronavirus Treatment With Natural Protein Cuts Risk of Death and Serious Symptoms by 79%    Good News Network

Local doctor provides tips for parents regarding this upcoming school year    KTIV

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils    Washington Post

Respiratory Syncytial Virus (RSV) Vaccines Market Outlook and Growth to 2030: GlaxoSmithKline, Novavax, Johnson & Johnson    3rd Watch News

Johnson & Johnson to start COVID-19 vaccine trials next week    European Pharmaceutical Review

Correlation between weather and COVID‐19 pandemic in India: An empirical investigation    Wiley

Fidelity Leads $97M Series C Round In Chinese Oncology Medicine Firm Antengene    China Money Network

Is Novavax Stock a Buy?    The Motley Fool

Johnson & Johnson to start COVID-19 vaccine trials next week    European Pharmaceutical Review

Moderna (MRNA) Confirms Publication in NEJM of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19    StreetInsider.com

Novavax (NVAX) Is a Long-Term Coronavirus Play    Nasdaq

Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic    Science Magazine

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization    PRNewswire

How a struggling biotech won $1.6 billion to make a coronavirus vaccine    Chicago Tribune

Is Novavax Stock a Buy?    The Motley Fool

How a struggling company won $1.6 billion to make a coronavirus vaccine    Morning Call

Why Is Everyone Talking About Quidel Stock?    The Motley Fool

IMV Updates Rapid Progress on COVID-19 Vaccine Program    Business Wire

Coronavirus Vaccine Race: Novavax or Vaxart?    Motley Fool

Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic    Science Magazine

Why Vaxart's Stock Is Trading Higher Today    Benzinga

How a struggling company won $1.6 billion to make a coronavirus vaccine    Hartford Courant

How a struggling company won $1.6 billion to make a coronavirus vaccine    Hartford Courant

How a struggling company won $1.6 billion to make a coronavirus vaccine    Hartford Courant

Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic    Science Magazine

As Covid-19 Vaccine Development Pushes Ahead, Researchers Probe Safety    The Wall Street Journal

Global Drugs For Respiratory Syncytial Virus (Rsv) Market COVID-19 Updated Analysis By Product (Ribavirin, Bronchodilator); By Application (Infants (Under 6 Month Old), Babies & Children, Adults)    NJ MMA News

IMV Updates Rapid Progress on COVID-19 Vaccine Program    Odessa American

Why Vaxart's Stock Is Trading Higher Today    Benzinga

Why follow-up appointments for children hospitalized for bronchiolitis may not be needed    ABC 4

Nova Scotia pharmaceutical company stocks jump after COVID-19 vaccine announcement    Cape Breton Post

Global RSV Diagnostics Market Growth is Projected to Grow at Sluggish Rate by 2027 Post COVID 19 Pandemic bioMérieux, Abbott, Roche, BD, Thermo Fisher    Bandera County Courier

Pre-Open Stock Movers 07/14: (IMV) (INMB) (TSLA) Higher; (OSMT) (MHK) (SPOT) Lower (more...)    StreetInsider.com

Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility    GlobeNewswire

Respiratory Syncytial Virus (RSV) MARKET TO WITNESS CONSIDERABLE UPSURGE DURING 2025    Jewish Life News

Growth of the Human Respiratory Syncytial Virus (RSV) Treatment Market Hinges on the Demand for 2016 – 2026    Jewish Life News

Biomedical Sciences Researcher Receives $3.65 Million Federal Grant to Develop Antiviral Drugs    Georgia State University News

High Demand for Respiratory Syncytial Virus (RSV) Cards from the Millennial Population to Foster the Growth of the Respiratory Syncytial Virus (RSV) Cards Market between 2018 – 2026    Jewish Life News

Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics Market Growth By Manufacturers, Type And Application, Forecast To 2026    3rd Watch News

Ozone gas could disinfect PPE for reuse    Futurity: Research News

CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate    Business Wire

Follow-up appointments for children hospitalized for bronchiolitis may not be needed    Medical Xpress

Vaccine developer receives $1.6B in Operation Warp Speed funding for COVID-19 treatment    The Denver Channel

Respiratory Syncytial Virus Therapeutics Market: Industry Analysis and forecast 2027: By Type of Causative Virus, Distribution Channel, and Region    Morning Tick

Emergent and J&J Ink COVID-19 Vaccine Deal    PharmaLive

Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus    BioSpace

Providers collaborate to offer COVID, flu tests | News, Sports, Jobs    Youngstown Vindicator

Vaccine developer receives $1.6B in Operation Warp Speed funding for COVID-19 treatment    WXYZ

Respiratory Syncytial Virus Therapeutics Market: Industry Analysis and forecast 2027: By Type of Causative Virus, Distribution Channel, and Region    Morning Tick

Rates of coinfection with other respiratory pathogens in patients positive for coronavirus disease 2019 (COVID‐19)    Wiley

Other news to note for July 7, 2020 | 2020-07-07 | BioWorld    BioWorld Online

Moms who will give birth in times of coronavirus don’t have to worry    Explica

Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV    Business Wire

GenMark launches ePlex RP2 Panel that detects respiratory pathogens    Medical Device Network

Global Respiratory Syncytial Virus Diagnostics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Becton, Dickinson and Co. | Technavio    Business Wire